Tolerability, pharmacokinetics and pharmacodynamics of ascending single and repeated doses of SAR444336 in healthy adult participants

Trial Identifier: TDR17161
Sponsor: Sanofi
NCTID:: NCT05876767
Start Date: October 2022
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Netherlands Netherlands